These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33484165)

  • 41. Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer's Disease.
    Dai Z; Hu T; Su S; Liu J; Ma Y; Zhuo Y; Fang S; Wang Q; Mo Z; Pan H; Fang J
    Front Pharmacol; 2022; 13():904857. PubMed ID: 35694256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
    Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H
    Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study on Urine Metabolic Profile of Aβ25-35-Induced Alzheimer's Disease Using UHPLC-Q-TOF-MS.
    Liu Y; Wei M; Yue K; Hu M; Li S; Men L; Pi Z; Liu Z; Liu Z
    Neuroscience; 2018 Dec; 394():30-43. PubMed ID: 30316910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer's Disease Pathogenesis.
    Ellis B; Hye A; Snowden SG
    J Alzheimers Dis; 2015; 46(2):313-27. PubMed ID: 25835424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
    Huan T; Tran T; Zheng J; Sapkota S; MacDonald SW; Camicioli R; Dixon RA; Li L
    J Alzheimers Dis; 2018; 65(4):1401-1416. PubMed ID: 30175979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma metabolomics and network pharmacology identified glutamate, glutamine, and arginine as biomarkers of depression under Shuganjieyu capsule treatment.
    Wang D; Gao Y; Li Y; Zhao Y; Du X; Li X; Zhang Y; Liu S; Xu Y
    J Pharm Biomed Anal; 2023 Aug; 232():115419. PubMed ID: 37146496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Explore the effects of Huang-Lian-Jie-Du-Tang on Alzheimer's disease by UPLC-QTOF/MS-based plasma metabolomics study.
    Sun LM; Zhu BJ; Cao HT; Zhang XY; Zhang QC; Xin GZ; Pan LM; Liu LF; Zhu HX
    J Pharm Biomed Anal; 2018 Mar; 151():75-83. PubMed ID: 29310050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection.
    Ding Y; Lin H; Chen X; Zhu B; Xu X; Xu X; Shen W; Gao M; He N
    EBioMedicine; 2021 Sep; 71():103548. PubMed ID: 34419928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics.
    Barba I; Fernandez-Montesinos R; Garcia-Dorado D; Pozo D
    J Cell Mol Med; 2008; 12(5A):1477-85. PubMed ID: 18554316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic profiles of cysteine, methionine, glutamate, glutamine, arginine, aspartate, asparagine, alanine and glutathione in Streptococcus thermophilus during pH-controlled batch fermentations.
    Qiao Y; Liu G; Leng C; Zhang Y; Lv X; Chen H; Sun J; Feng Z
    Sci Rep; 2018 Aug; 8(1):12441. PubMed ID: 30127376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
    Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
    J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia.
    Mastrangelo A; Scotti GM; Manteiga JG; Gisslén M; Price RW; Bestetti A; Turrini F; Caccia R; Gorelik L; Morelli MJ; Castagna A; Cinque P
    AIDS; 2024 Mar; 38(3):299-308. PubMed ID: 37905996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis in treating Alzheimer's disease using UPLC-Q-TOF-MS.
    Wei M; Liu Z; Liu Y; Li S; Hu M; Yue K; Liu T; He Y; Pi Z; Liu Z; Song F
    Food Funct; 2019 Sep; 10(9):5656-5668. PubMed ID: 31433414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer's Disease.
    Huang YL; Lin CH; Tsai TH; Huang CH; Li JL; Chen LK; Li CH; Tsai TF; Wang PN
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic effect and mechanism of
    Wang H; Dai JY; He YZ; Xia ZW; Chen XF; Hong ZY; Chai YF
    Front Pharmacol; 2022; 13():940555. PubMed ID: 35991874
    [No Abstract]   [Full Text] [Related]  

  • 57. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.
    Huo Z; Yu L; Yang J; Zhu Y; Bennett DA; Zhao J
    Neurobiol Aging; 2020 Feb; 86():123-133. PubMed ID: 31785839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
    Oberacher H; Arnhard K; Linhart C; Diwo A; Marksteiner J; Humpel C
    J Alzheimers Dis; 2017; 57(2):493-504. PubMed ID: 28269764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeted metabolomics study of early pathological features in hippocampus of triple transgenic Alzheimer's disease male mice.
    Zhao Y; Chen H; Iqbal J; Liu X; Zhang H; Xiao S; Jin N; Yao F; Shen L
    J Neurosci Res; 2021 Mar; 99(3):927-946. PubMed ID: 33197957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salivaomics as a Potential Tool for Predicting Alzheimer's Disease During the Early Stages of Neurodegeneration.
    François M; Karpe A; Liu JW; Beale D; Hor M; Hecker J; Faunt J; Maddison J; Johns S; Doecke J; Rose S; Leifert WR
    J Alzheimers Dis; 2021; 82(3):1301-1313. PubMed ID: 34151801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.